Muscarinic-3-receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2022 at "Neurourology and urodynamics"
DOI: 10.1002/nau.24931
Abstract: AIM The aim of this study is to evaluate safety and efficacy of ASP8302, a novel positive allosteric modulator for the muscarinic M3 receptor (M3-PAM), in patients with underactive bladder (UAB). METHODS A randomized, double-blind,… read more here.
Keywords: muscarinic receptor; allosteric modulator; placebo; bladder ... See more keywords